The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IB/II first line panitumumab, irinotecan, trifluridine/tipiracil in RAS wild-type patients with metastatic colorectal cancer: PIT study.
 
Timothy Jay Price
Consulting or Advisory Role - Amgen; Astrazeneca (Inst); BMS (Inst); Merck; Takeda
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen
 
Rohit Joshi
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Ipsen; Merck Sharp & Dohme; Pfizer; Pfizer/EMD Serono; Roche
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche
Speakers' Bureau - Gilead Sciences
Travel, Accommodations, Expenses - Novartis
 
Christos Stelios Karapetis
Honoraria - Eisai; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Lilly; Merck Serono; Pierre Fabre; Roche; Takeda
 
Pam Cooper
No Relationships to Disclose
 
Chris Hocking
No Relationships to Disclose
 
Nimit Singhal
No Relationships to Disclose
 
Amanda Rose Townsend
No Relationships to Disclose